Cited by 135Antibiotic Use and ResistancePharmaceutical Economics and PolicyAntibiotic Resistance in Bacteria

Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico

Open access
Santa-Ana-Tellez, Yared, Mantel-Teeuwisse, Aukje K., Dreser, Anahi, Leufkens, Hubert G. M., Wirtz, Veronika J.·2013·PLoS ONE

Abstract

BACKGROUND: In Latin American countries over-the-counter (OTC) dispensing of antibiotics is common. In 2010, both Mexico and Brazil implemented policies to enforce existing laws of restricting consumption of antibiotics only to patients presenting a prescription. The objective of the present study is therefore to evaluate the impact of OTC restrictions (2010) on antibiotics consumption in Brazil and Mexico. METHODS AND FINDINGS: Retail quarterly sales data in kilograms of oral and injectable antibiotics between January 2007 and June 2012 for Brazil and Mexico were obtained from IMS Health. The unit of analysis for antibiotics consumption was the defined daily dose per 1,000 inhabitants per day (DDD/TID) according to the WHO ATC classification system. Interrupted time series analysis was conducted using antihypertensives as reference group to account for changes occurring independently of the OTC restrictions directed at antibiotics. To reduce the effect of (a) seasonality and (b) autocorrelation, dummy variables and Prais-Winsten regression were used respectively. Between 2007 and 2012 total antibiotic usage increased in Brazil (from 5.7 to 8.5 DDD/TID, +49.3%) and decreased in Mexico (10.5 to 7.5 DDD/TID, -29.2%). Interrupted time series analysis showed a change in level of consumption of -1.35 DDD/TID (p<0.01) for Brazil and -1.17 DDD/TID (p<0.00) for Mexico. In Brazil the penicillins, sulfonamides and macrolides consumption had a decrease in level after the intervention of 0.64 DDD/TID (p = 0.02), 0.41 (p = 0.02) and 0.47 (p = 0.01) respectively. While in Mexico it was found that only penicillins and sulfonamides had significant changes in level of -0.86 DDD/TID (p<0.00) and -0.17 DDD/TID (p = 0.07). CONCLUSIONS: Despite different overall usage patterns of antibiotics in Brazil and Mexico, the effect of the OTC restrictions on antibiotics usage was similar. In Brazil the trend of increased usage of antibiotics was tempered after the OTC restrictions; in Mexico the trend of decreased usage was boosted.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0075550

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies in Zimbabwe, Chile, Colombia, Brazil, Mexico, Korea and Saudi Arabia found strict enforcement of existing laws to be effective in containing non-prescribed antibiotic provision.

    “A number of studies conducted in Zimbabwe, Chile, Colombia, Brazil, Mexico and Korea in addition to a study completed in Saudi Arabia found strict enforcement of existing laws to be effective in containing the non-prescribed antibiotics provision [61–65].”

    From No prescription? No problem: drivers of non-prescribed sale of antibiotics among community drug retail outlets in low and middle income countries: a systematic review of qualitative studies (2021) · cites this paper as [63]

    The Background and Discussion report that Brazil and Mexico enforced prescription requirements and subsequently saw an immediate decrease in private-sector antibiotic consumption. The study measured overall consumption, not the provision of antibiotics without prescriptions, so it does not directly establish that outcome. Its Introduction and Discussion also report effects in Chile and Colombia, but it did not study Zimbabwe, Korea, or Saudi Arabia. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Dreser, A., Leufkens, H. G. M., & Wirtz, V. J.
Affiliations
  • Utrecht University (NL)
  • Boston University (US)
Corresponding author
  • Mantel-Teeuwisse, Aukje K.
  • Leufkens, Hubert G. M.
  • Wirtz, Veronika J.
Venue
PLoS ONE
Published
2013-10-16
Volume
8
Issue
10
Pages
e75550
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1978318446
Cited by
135
References
13
Citations by year
2026: 4 · 2025: 4 · 2024: 12 · 2023: 8 · 2022: 21 · 2021: 19 · 2020: 18 · 2019: 13 · 2018: 11 · 2017: 5 · 2016: 8 · 2015: 10 · 2014: 2
FWCI
5.90
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • ZonMw
  • College ter Beoordeling van Geneesmiddelen
  • Consejo Nacional de Ciencia y Tecnología
  • Top Institute Pharma
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
Keywords
antibiotic use, defined daily doses, penicillin, sulfonamides, macrolides, antimicrobial policy, Brazil, Mexico, Latin America
MeSH terms
Anti-Bacterial Agents, Brazil, Drug Utilization, Nonprescription Drugs, Humans, Mexico, Prescription Drug Misuse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review